49
Participants
Start Date
April 27, 2018
Primary Completion Date
October 5, 2018
Study Completion Date
October 5, 2018
AG10
TTR stabilizer
Placebo Oral Tablet
Nonactive control
Columbia University, New York
Medical University of South Carolina, Charleston
Cleveland Clinic, Cleveland
Mayo Clinic, Rochester
Northwestern University, Chicago
University of Utah, Salt Lake City
Cedars-Sinai Medical Center, Beverly Hills
University of California San Francisco, San Francisco
Stanford University, Palo Alto
Oregon Health & Science University, Portland
Yale University, New Haven
Brigham and Women's Hospital, Boston
Boston University, Boston
Eidos Therapeutics, a BridgeBio company
INDUSTRY